Lansoprazole for injection in Wuzhong, Jiangsu Province will add a new army of drugs for digestive tract

According to the information released by the State Food and Drug Administration (CFDA), Lansoprazole for injection, a new class 3 chemical drug in Wuzhong, Jiangsu Province (600200 SH), will undergo on-site inspection this month According to the new drug review process, this is the last inspection link of drug production Industry insiders said that after successfully passing the on-site inspection, the drug will be approved for marketing in a few months Jiangsu Wuzhong's relevant person in charge told the big wisdom news agency that the CFDA has been informed of the above publicity, and the preliminary plan is that the relevant national departments will come to conduct on-site inspection in October "Lansoprazole is a new generation of gastric ulcer and stomach disease treatment The competition is very fierce, so the time of approval is very important If it is approved earlier, it will occupy the market earlier It is understood that Lansoprazole for injection is used in the digestive system for the treatment of gastric and duodenal ulcer At present, 7 domestic enterprises have obtained production approval documents, and more than 10 enterprises are applying for production The above person in charge further said that lansoprazole will be used as an updated product of the company's existing omeprazole, enriching the product line of gastrointestinal medicine "At present, the market is quite recognized for lansoprazole With the start of a new round of bidding, the company also hopes to seize the time as much as possible to make the upgraded products supplement the existing products." The person in charge also said that the digestive system medicine is a key development direction of the company, and the company will do series development around the digestive system medicine In addition to omeprazole and lansoprazole, there are a series of new gastrointestinal drugs in different degrees of research and development